BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 10563193)

  • 1. Monitoring of interobserver agreement in nuclear atypia scoring of node-negative breast carcinomas judged at individual collaborating hospitals in the National Surgical Adjuvant Study of Breast Cancer (NSAS-BC) protocol.
    Tsuda H; Akiyama F; Kurosumi M; Sakamoto G; Watanabe T
    Jpn J Clin Oncol; 1999 Sep; 29(9):413-20. PubMed ID: 10563193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy and limitations of repeated slide conferences for improving interobserver agreement when judging nuclear atypia of breast cancer. The Japan National Surgical Adjuvant Study of Breast Cancer (NSAS-BC) Pathology Section.
    Tsuda H; Akiyama F; Kurosumi M; Sakamoto G; Watanabe T
    Jpn J Clin Oncol; 1999 Feb; 29(2):68-73. PubMed ID: 10089946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the interobserver agreement in the number of mitotic figures of breast carcinoma as simulation of quality monitoring in the Japan National Surgical Adjuvant Study of Breast Cancer (NSAS-BC) protocol.
    Tsuda H; Akiyama F; Kurosumi M; Sakamoto G; Yamashiro K; Oyama T; Hasebe T; Kameyama K; Hasegawa T; Umemura S; Honma K; Ozawa T; Sasaki K; Morino H; Ohsumi S
    Jpn J Cancer Res; 2000 Apr; 91(4):451-7. PubMed ID: 10804295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A quantitative model using mean and standard deviation for evaluation of interobserver agreement in nuclear atypia scoring of breast carcinomas in a protocol study.
    Tsuda H; Akiyama F; Kurosumi M; Sakamoto G; Watanabe T
    Pathol Int; 2000 Feb; 50(2):119-25. PubMed ID: 10792770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of histological criteria for high-risk node-negative breast carcinoma for a multi-institutional randomized clinical trial of adjuvant therapy. Japan National Surgical Adjuvant Study of Breast Cancer (NSAS-BC) Pathology Section.
    Tsuda H; Akiyama F; Kurosumi M; Sakamoto G; Watanabe T
    Jpn J Clin Oncol; 1998 Aug; 28(8):486-91. PubMed ID: 9769782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic concordance among pathologists interpreting breast biopsy specimens.
    Elmore JG; Longton GM; Carney PA; Geller BM; Onega T; Tosteson AN; Nelson HD; Pepe MS; Allison KH; Schnitt SJ; O'Malley FP; Weaver DL
    JAMA; 2015 Mar; 313(11):1122-32. PubMed ID: 25781441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear grade and comedo necrosis of ductal carcinoma in situ as histopathological eligible criteria for the Japan Clinical Oncology Group 1505 trial: an interobserver agreement study.
    Tsuda H; Yoshida M; Akiyama F; Ohi Y; Kinowaki K; Kumaki N; Kondo Y; Saito A; Sasaki E; Nishimura R; Fujii S; Homma K; Horii R; Murata Y; Itami M; Kajita S; Kato H; Kurosumi M; Sakatani T; Shimizu S; Taniguchi K; Tamiya S; Nakamura H; Kanbayashi C; Shien T; Iwata H
    Jpn J Clin Oncol; 2021 Mar; 51(3):434-443. PubMed ID: 33420502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor budding in colorectal carcinoma: An institutional interobserver reliability and prognostic study of colorectal adenocarcinoma cases.
    Hacking S; Angert M; Jin C; Kline M; Gupta N; Cho M; Thomas R; Lee L; Chavarria H; Nasim M
    Ann Diagn Pathol; 2019 Dec; 43():151420. PubMed ID: 31731034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of 12 strategies for obtaining second opinions to improve interpretation of breast histopathology: simulation study.
    Elmore JG; Tosteson AN; Pepe MS; Longton GM; Nelson HD; Geller B; Carney PA; Onega T; Allison KH; Jackson SL; Weaver DL
    BMJ; 2016 Jun; 353():i3069. PubMed ID: 27334105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interobserver variability in upfront dichotomous histopathological assessment of ductal carcinoma in situ of the breast: the DCISion study.
    Dano H; Altinay S; Arnould L; Bletard N; Colpaert C; Dedeurwaerdere F; Dessauvagie B; Duwel V; Floris G; Fox S; Gerosa C; Jaffer S; Kurpershoek E; Lacroix-Triki M; Laka A; Lambein K; MacGrogan GM; Marchió C; Martinez DM; Nofech-Mozes S; Peeters D; Ravarino A; Reisenbichler E; Resetkova E; Sanati S; Schelfhout AM; Schelfhout V; Shaaban AM; Sinke R; Stanciu-Pop CM; Stobbe C; van Deurzen CHM; Van de Vijver K; Van Rompuy AS; Verschuere S; Vincent-Salomon A; Wen H; Bouzin C; Galant C; Van Bockstal MR
    Mod Pathol; 2020 Mar; 33(3):354-366. PubMed ID: 31534203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic Reproducibility: What Happens When the Same Pathologist Interprets the Same Breast Biopsy Specimen at Two Points in Time?
    Jackson SL; Frederick PD; Pepe MS; Nelson HD; Weaver DL; Allison KH; Carney PA; Geller BM; Tosteson AN; Onega T; Elmore JG
    Ann Surg Oncol; 2017 May; 24(5):1234-1241. PubMed ID: 27913946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Papillary lesions of the breast: impact of breast pathology subspecialization on core biopsy and excision diagnoses.
    Jakate K; De Brot M; Goldberg F; Muradali D; O'Malley FP; Mulligan AM
    Am J Surg Pathol; 2012 Apr; 36(4):544-51. PubMed ID: 22314186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computer-Assisted Nuclear Atypia Scoring of Breast Cancer: a Preliminary Study.
    Gandomkar Z; Brennan PC; Mello-Thoms C
    J Digit Imaging; 2019 Oct; 32(5):702-712. PubMed ID: 30719586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interobserver variation in the diagnosis of fibroepithelial lesions of the breast: a multicentre audit by digital pathology.
    Dessauvagie BF; Lee AHS; Meehan K; Nijhawan A; Tan PH; Thomas J; Tie B; Treanor D; Umar S; Hanby AM; Millican-Slater R
    J Clin Pathol; 2018 Aug; 71(8):672-679. PubMed ID: 29440134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interobserver reproducibility of the Nottingham modification of the Bloom and Richardson histologic grading scheme for infiltrating ductal carcinoma.
    Frierson HF; Wolber RA; Berean KW; Franquemont DW; Gaffey MJ; Boyd JC; Wilbur DC
    Am J Clin Pathol; 1995 Feb; 103(2):195-8. PubMed ID: 7856562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histological grading of breast carcinomas: a study of interobserver agreement.
    Robbins P; Pinder S; de Klerk N; Dawkins H; Harvey J; Sterrett G; Ellis I; Elston C
    Hum Pathol; 1995 Aug; 26(8):873-9. PubMed ID: 7635449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histologic grading of breast carcinoma: a multi-institution study of interobserver variation using virtual microscopy.
    Ginter PS; Idress R; D'Alfonso TM; Fineberg S; Jaffer S; Sattar AK; Chagpar A; Wilson P; Harigopal M
    Mod Pathol; 2021 Apr; 34(4):701-709. PubMed ID: 33077923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interobserver variability in breast carcinoma grading results in prognostic stage differences.
    Rabe K; Snir OL; Bossuyt V; Harigopal M; Celli R; Reisenbichler ES
    Hum Pathol; 2019 Dec; 94():51-57. PubMed ID: 31655171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An International Interobserver Variability Reporting of the Nuclear Scoring Criteria to Diagnose Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features: a Validation Study.
    Thompson LDR; Poller DN; Kakudo K; Burchette R; Nikiforov YE; Seethala RR
    Endocr Pathol; 2018 Sep; 29(3):242-249. PubMed ID: 29508145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interobserver reproducibility in the pathologic diagnosis of borderline ductal proliferative breast diseases].
    Wei B; Bu H; Zhu CR; Guo LX; Chen HJ; Zhao C; Zhang P; Chen DY; Tang Y; Jiang Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Nov; 35(6):849-53. PubMed ID: 15573772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.